Clear Labs
San Carlos, US · Founded 2014 · Delaware corporation · 9 known investors
Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology. The company serves laboratories, food brands, healthcare systems, and diagnostic organizations.
Founders & leadership
SA
Sasan AminiCo-founder & CEO
RK
Ramin KhaksarinExecutive Officer
EF
Edward FaninExecutive Officer
BF
Brodie FlandersExecutive Officer, Director
CP
Charlie PiperDirector
NH
Nicolas H. RoelofsDirector
KO
Kazutaka OhnoExecutive Officer
GY
Greg YapDirector
GG
Gaurav GargDirector
MF
Ming FangDirector
MR
Mostafa RonaghiDirector
Investors · 9
Menlo Ventures✓ verifiedSan Francisco · $1M – $20M
Khosla Ventures✓ verifiedMenlo Park · $5K – $50M
Nimble Ventures✓ verifiedSan Franciscovia Juan Scarlett · inferred
Dentsu VenturesTokyo
Felicis VenturesSan Francisco · $500K – $15M
Nimble PartnersSan Francisco
Prime PartnersTokyo
SGH CapitalParis
WingPalo Alto · $200K – $20M
Reported raises · per SEC filings
Form D private placements▶$29.1MraisedDec 2024 · 33 investors · BiotechnologyRule 506(b)
▶$29.1MraisedDec 2024 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Greg YapDirector
- Gaurav GargDirector
- Mostafa RonaghiDirector
- Sasan AminiExecutive Officer, Director
- Ming FangDirector
- Ramin KhaksarExecutive Officer
- Edward FanExecutive Officer
- Offering amount
- $50M
- Amount sold
- $29.1M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60MraisedMay 2021 · 30 investors · BiotechnologyRule 506(b)
▶$60MraisedMay 2021 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff FieldExecutive Officer
- Ramin KhaksarExecutive Officer
- Mostafa RonaghiDirector
- Gaurav GargDirector
- Michael TaylorDirector
- Sasan AminiExecutive Officer, Director
- Michael RobachDirector
- Greg YapDirector
- Brian HoganExecutive Officer
- Offering amount
- $70M
- Amount sold
- $60M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$39.5MraisedMay 2020 · 28 investors · BiotechnologyRule 506(b)
▶$39.5MraisedMay 2020 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael RobachDirector
- Gaurav GargDirector
- Greg YapDirector
- Mostafa RonaghiDirector
- Sasan AminiExecutive Officer, Director
- Michael TaylorDirector
- Offering amount
- $41M
- Amount sold
- $39.5M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedSep 2015 · 21 investors · Other TechnologyRule 506(b)
▶$6.2MraisedSep 2015 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sasan AminiExecutive Officer
- Charlie PiperDirector
- Nicolas H. RoelofsDirector
- Mostafa RonaghiDirector
- Kazutaka OhnoExecutive Officer
- Offering amount
- $6.5M
- Amount sold
- $6.2M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$193.8KofferedSep 2015 · Other Health CareRule 506(b)
▶$193.8KofferedSep 2015 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brodie FlandersExecutive Officer, Director
- Offering amount
- $193.8K
- Minimum investment
- $1.3K
- Incorporated
- Limited Liability Company, Texas, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing Solutionsprweb.com · 2025
- Clear Labs Raises $60M in Series C Financing Round | GenomeWebgenomeweb.com · 2021
- Food safety tester Clear Labs raises $60M to chase COVID-19 variants | Fierce Biotechfiercebiotech.com · 2021
- Clear Labs Raises $18M in Funding - FinSMEsfinsmes.com · 2020
- About Clear Labs - Clear Labsclearlabs.com · 2018